Next Article in Journal
Evaluation of the Sleep-Prolonging Effect of Lagenaria vulgaris and Cucurbita pepo Extracts on Pentobarbital-Induced Sleep and Possible Mechanisms of Action
Previous Article in Journal
Midbody: From the Regulator of Cytokinesis to Postmitotic Signaling Organelle
Article

Serum and Tissue HIF-2 Alpha Expression in CIN, N-Acetyl Cysteine, and Sildenafil-Treated Rat Models: An Experimental Study

1
Department of Emergency Medicine, Kayseri Training and Research Hospital, 38010 Kayseri, Turkey
2
Department of Biochemistry, Kayseri Training and Research Hospital, 38010 Kayseri, Turkey
3
Experimantal Research Center, Erciyes University, 38010 Kayseri, Turkey
4
Department of Histology and Embryology, University of Erciyes, 38010 Kayseri, Turkey
5
Department of Biostatistics, Erciyes University Faculty of Medicine, 38010 Kayseri, Turkey
*
Author to whom correspondence should be addressed.
Received: 25 June 2018 / Revised: 26 July 2018 / Accepted: 26 July 2018 / Published: 30 July 2018
Background and Objectives: Contrast-induced nephropathy (CIN), is acute renal damage due to contrast agents. This study is conducted to evaluate serum and renal heterodimeric nuclear transcription factor (HIF)-2 alpha levels and its tissue expression in contrast-induced nephropathy, and in N-acetyl cysteine (NAC)-and Sildenafil-treated rat models. Materials/Methods: This randomized, controlled, interventional animal study was conducted on Wistar rats. Rats (n = 36) were randomly assigned to four groups: control (n = 9), CIN group (n = 9), CIN + NAC group (n = 9), and sildenafil (n = 9). The rat model was used to form iohexol-originated CIN. During the modeling, prophylactic treatment was performed at the 24th and 48th h. After 48 h of modeling, blood, urine, and tissue samples were obtained for biochemical analyses. HIF-2-α levels were measured in renal tissue, serum, and urine samples. Renal sections were also performed for histopathologic and immunohistochemical evaluations of renal injury and HIF-2-α expression. Results: In the CIN model, HIF-2α levels and other biochemical parameters were significantly increased (p < 0.01). Both sildenafil and NAC efficiently decreased renal damage due to contrast agents, as shown in histopathologic examinations (p < 0.05). Similarly, after treatment with sildenafil and NAC, HIF-2α levels were significantly decreased (p < 0.05). Conclusions: The current study shows that serum and tissue HIF-2α levels decrease in CIN. Besides, the levels and tissue expression of HIF-2α decrease with both NAC and sildenafil treatments. With further studies, HIF-2α can be investigated as a biomarker of CIN and can be used in the follow-up of patients with CIN. View Full-Text
Keywords: contrast-induced nephropathy; hypoxia-inducible factor 2α; N-acetyl-cysteine; sildenafil contrast-induced nephropathy; hypoxia-inducible factor 2α; N-acetyl-cysteine; sildenafil
Show Figures

Figure 1

MDPI and ACS Style

Altintop, I.; Tatli, M.; Karakukcu, C.; Soyer Sarica, Z.; Hanım Yay, A.; Balcioglu, E.; Ozturk, A. Serum and Tissue HIF-2 Alpha Expression in CIN, N-Acetyl Cysteine, and Sildenafil-Treated Rat Models: An Experimental Study. Medicina 2018, 54, 54. https://0-doi-org.brum.beds.ac.uk/10.3390/medicina54040054

AMA Style

Altintop I, Tatli M, Karakukcu C, Soyer Sarica Z, Hanım Yay A, Balcioglu E, Ozturk A. Serum and Tissue HIF-2 Alpha Expression in CIN, N-Acetyl Cysteine, and Sildenafil-Treated Rat Models: An Experimental Study. Medicina. 2018; 54(4):54. https://0-doi-org.brum.beds.ac.uk/10.3390/medicina54040054

Chicago/Turabian Style

Altintop, Ismail, Mehmet Tatli, Cigdem Karakukcu, Zeynep Soyer Sarica, Arzu Hanım Yay, Esra Balcioglu, and Ahmet Ozturk. 2018. "Serum and Tissue HIF-2 Alpha Expression in CIN, N-Acetyl Cysteine, and Sildenafil-Treated Rat Models: An Experimental Study" Medicina 54, no. 4: 54. https://0-doi-org.brum.beds.ac.uk/10.3390/medicina54040054

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop